A Single Center, Randomized, Open-Label, Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan. Does Trexime Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?

Trial Profile

A Single Center, Randomized, Open-Label, Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan. Does Trexime Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2016

At a glance

  • Drugs Naproxen sodium/sumatriptan (Primary) ; Tryptamines
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms TRXvUsualTrptn
  • Most Recent Events

    • 10 Aug 2016 Status changed from recruiting to completed.
    • 05 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
    • 23 Jun 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top